Next Article in Journal
Antioxidative Peptides Derived from Enzyme Hydrolysis of Bone Collagen after Microwave Assisted Acid Pre-Treatment and Nitrogen Protection
Next Article in Special Issue
Proteomic Analysis of Whole Human Saliva Detects Enhanced Expression of Interleukin-1 Receptor Antagonist, Thioredoxin and Lipocalin-1 in Cigarette Smokers Compared to Non-Smokers
Previous Article in Journal
The Bondons: The Quantum Particles of the Chemical Bond
Previous Article in Special Issue
Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs
Review

α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease

Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2010, 11(11), 4257-4266; https://doi.org/10.3390/ijms11114257
Received: 14 September 2010 / Revised: 20 October 2010 / Accepted: 28 October 2010 / Published: 29 October 2010
(This article belongs to the Special Issue Biomarkers)
Parkinson’s disease (PD) is the most common form of movement disorder and affects approximately 4% of the population aged over 80 years old. Currently, PD cannot be prevented or cured, and no single diagnostic biomarkers are available. Notably, recent studies suggest that two familial PD-linked molecules, α-synuclein and DJ-1, are present in cerebrospinal fluid (CSF) and that their levels may be altered during the progression of PD. In this regard, sensitive and accurate methods for evaluation of α-synuclein and DJ-1 levels in the CSF and blood have been developed, and the results suggest that the levels of both molecules are significantly decreased in the CSF in patients with PD compared with age-matched controls. Furthermore, specific detection and quantification of neurotoxic oligometric forms of α-synuclein in the blood using enzyme-linked immunosorbent assays might be expected as potential peripheral biomarkers for PD, although further validation is required. Currently, neither α-synuclein nor DJ-1 is satisfactory as a single biomarker for PD, but combinatory evaluation of these biological fluid molecules with other biomarkers and imaging techniques may provide reliable information for diagnosis of PD. View Full-Text
Keywords: Parkinson’s disease; cerebrospinal fluid; biomarker; α-synuclein; DJ-1 Parkinson’s disease; cerebrospinal fluid; biomarker; α-synuclein; DJ-1
MDPI and ACS Style

Waragai, M.; Sekiyama, K.; Sekigawa, A.; Takamatsu, Y.; Fujita, M.; Hashimoto, M. α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease. Int. J. Mol. Sci. 2010, 11, 4257-4266. https://doi.org/10.3390/ijms11114257

AMA Style

Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M. α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease. International Journal of Molecular Sciences. 2010; 11(11):4257-4266. https://doi.org/10.3390/ijms11114257

Chicago/Turabian Style

Waragai, Masaaki, Kazunari Sekiyama, Akio Sekigawa, Yoshiki Takamatsu, Masayo Fujita, and Makoto Hashimoto. 2010. "α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease" International Journal of Molecular Sciences 11, no. 11: 4257-4266. https://doi.org/10.3390/ijms11114257

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop